19 results
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
14 Aug 23
Tender and Support Agreement
7:42am
TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
SC TO-C
EX-99.1
HRMY
Harmony Biosciences Holdings Inc
14 Aug 23
Information about tender offer
5:29pm
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY
SC TO-T
EX-99
ZYNE
Zynerba Pharmaceuticals, Inc.
28 Aug 23
Third party tender offer statement
8:23am
appeal from, such final court judgment.
(c) EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT
SC TO-C
EX-2.1
HRMY
Harmony Biosciences Holdings Inc
14 Aug 23
Information about tender offer
5:29pm
equitable relief and other monetary damages, remedies or awards.
(b)EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY … )EACH OF THE PARTIES TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED
8-K
EX-2.1
dzs9 5p88yb8eyl
14 Aug 23
Tender and Support Agreement
7:42am
424B5
2wnoga
12 May 21
Prospectus supplement for primary offering
9:22am
424B5
i6jwcis8wyi
21 Jul 22
Prospectus supplement for primary offering
7:36am
424B5
zgboe0ia gzy8io
30 Aug 19
Prospectus supplement for primary offering
4:27pm
10-K
1e0au5
14 Mar 16
Annual report
12:00am
DRS/A
yraaylwsd9fp hpn
20 Feb 15
Draft registration statement (amended)
12:00am
DRS
998wemqs
12 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next